Organic compositions to treat HSF1-related diseases
Abstract:
The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.
Public/Granted literature
Information query
Patent Agency Ranking
0/0